Collaborative Care Diagnostics

CC Diagnostics is a Dutch medical technology company focused on improving cancer screening through advanced molecular diagnostics. The company has developed a proprietary triage test for cervical cancer that utilizes DNA methylation markers to accurately identify high-grade cervical lesions in women who test positive for high-risk HPV. This approach aims to replace or supplement traditional cytology, reducing the number of false positives and unnecessary colposcopies. The company's technology is designed to be easily integrated into existing laboratory workflows, providing a scalable solution for national screening programs. By focusing on epigenetic changes, CC Diagnostics provides a more objective and automated alternative to the subjective nature of Pap smears.